Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Celluxtreme AB
AB
Active
Org 5592911993
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 5 years old
5 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Celluxtreme AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
118
323
440
868
1 075
Staff expenses
—
−520
−1 345
−2 354
−3 119
EBITDA
32
20
23
327
372
Depreciation & amort.
−0
—
—
−68
−139
EBIT
32
20
23
259
234
Net financials
—
0
−21
−64
−73
Profit before tax
23
20
12
145
119
Tax
−6
−4
−3
−31
−26
Net profit
17
16
9
115
94
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
193
1 547
2 870
4 931
6 968
Equity
42
58
69
184
278
Long-term debt
0
—
1 281
669
113
Short-term debt
141
1 480
1 520
4 030
6 487
Total debt
141
1 480
2 801
4 698
6 600
Financial ratios
5-year trend
EBITDA-margin
34.7%
This company
15.8%
Market median
+120% vs market
2021
2025
Soliditetsgrad
4.0%
This company
38.2%
Market median
-90% vs market
2021
2025
Egenkapitalforrentning
33.8%
This company
18.4%
Market median
+84% vs market
2021
2025
Nettoresultatgrad
8.7%
This company
8.1%
Market median
+7% vs market
2021
2025
Aktivomsætning
0.15×
This company
1.12×
Market median
-87% vs market
2021
2025
Gæld/egenkapital
24.09×
This company
0.62×
Market median
-3785% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
View
PDF
More on Celluxtreme AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
